BiotechTube

Ad26.ZEBOV vaccine

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Ebola Virus Disease

Conditions

Ebola Virus Disease

Trial Timeline

Dec 18, 2019 → Oct 12, 2022

NCT ID
NCT04186000

About Ad26.ZEBOV vaccine

Ad26.ZEBOV vaccine is a phase 2 stage product being developed by Johnson & Johnson for Ebola Virus Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT04186000. Target conditions include Ebola Virus Disease.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT04186000Phase 2Completed

Competing Products

20 competing products in Ebola Virus Disease

See all competitors
ProductCompanyStageHype Score
rVSVΔG-ZEBOV-GP, V920 + Chikenpox or Varicella vaccine (VARILRIX)MerckPhase 1/2
41
V920 VaccineMerckPhase 1
33
Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSV∆G-ZEBOV-GP)MerckPhase 2
52
rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO)MerckApproved
85
V920 (rVSVΔG-ZEBOV-GP) Ebola Virus VaccineMerckPhase 2
52
V920MerckPhase 1
33
V920 Consistency Lot A + V920 Consistency Lot B + V920 Consistency Lot C + V920 High-dose Lot + Placebo to V920MerckPhase 3
77
BioNTech - Pfizer COVID-19 vaccine + 1mL saline solution + rVSV∆G-ZEBOV-GPMerckApproved
85
V920MerckPhase 1
33
GS-5734Gilead SciencesPhase 2
51
REGN3470-3471-3479Regeneron PharmaceuticalsPre-clinical
22
Ervebo + InmazebRegeneron PharmaceuticalsPhase 2
51
AVI-7537United TherapeuticsPhase 1
30
Placebo + AVI-6002United TherapeuticsPhase 1
30
Ad26.ZEBOV + MVA-BN-FiloBavarian NordicPhase 3
74
CMX001Jazz PharmaceuticalsPhase 2
49
BrincidofovirJazz PharmaceuticalsPhase 2
49
cAd3-Marburg + cAd3-EBO-SICON plc.Phase 1
30
Base Dose EBOV GP Vaccine + 2x Base Dose EBOV GP Vaccine + 4x Base Dose EBOV GP Vaccine + 8x Base Dose EBOV GP Vaccine + Placebo + Matrix-M AdjuvantNovavaxPhase 1
28
TKM-100802 for Injection + PlaceboArbutus BiopharmaPhase 1
28

Other Products from Johnson & Johnson

Fentanyl transdermal therapeutic systemApproved
85
Nicotine Gum + Nicotine PatchApproved
85
galantamineApproved
85
IbrutinibApproved
85
Paliperidone ERApproved
85